Pro-Dex, Inc. (PDEX)
USD 45.73
(-5.61%)
USD 45.73
(-5.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 23.34 Million USD | 6.81% |
| 2023 | 20.23 Million USD | -14.48% |
| 2022 | 23.65 Million USD | 16.91% |
| 2021 | 20.23 Million USD | 67.74% |
| 2020 | 12.06 Million USD | 41.73% |
| 2019 | 8.51 Million USD | 222.3% |
| 2018 | 2.64 Million USD | 0.0% |
| 2017 | 2.64 Million USD | 16.34% |
| 2016 | 2.27 Million USD | -43.78% |
| 2015 | 4.03 Million USD | 62.04% |
| 2014 | 2.49 Million USD | -6.25% |
| 2013 | 2.65 Million USD | -18.77% |
| 2012 | 3.27 Million USD | -37.52% |
| 2011 | 5.23 Million USD | -21.41% |
| 2010 | 6.66 Million USD | 11.35% |
| 2009 | 5.98 Million USD | -28.52% |
| 2008 | 8.37 Million USD | 59.3% |
| 2007 | 5.25 Million USD | -7.48% |
| 2006 | 5.68 Million USD | 245.77% |
| 2005 | 1.64 Million USD | -22.9% |
| 2004 | 2.13 Million USD | 28.22% |
| 2003 | 1.66 Million USD | -37.28% |
| 2002 | 2.65 Million USD | -8.56% |
| 2001 | 2.89 Million USD | -72.38% |
| 2000 | 10.49 Million USD | -22.11% |
| 1999 | 13.47 Million USD | 39.19% |
| 1998 | 9.67 Million USD | -15.1% |
| 1997 | 11.4 Million USD | 4.59% |
| 1996 | 10.9 Million USD | 505.56% |
| 1995 | 1.8 Million USD | 12.5% |
| 1994 | 1.6 Million USD | -5.88% |
| 1993 | 1.7 Million USD | 41.67% |
| 1992 | 1.2 Million USD | 50.0% |
| 1991 | 800 Thousand USD | -52.94% |
| 1990 | 1.7 Million USD | -5.56% |
| 1989 | 1.8 Million USD | -5.26% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 19.61 Million USD | -0.16% |
| 2024 Q2 | 19.64 Million USD | 6.8% |
| 2024 Q1 | 18.39 Million USD | -9.11% |
| 2024 Q4 | 23.34 Million USD | 19.04% |
| 2024 FY | 23.34 Million USD | 15.37% |
| 2023 Q4 | 20.23 Million USD | -4.27% |
| 2023 Q3 | 21.13 Million USD | -8.52% |
| 2023 Q2 | 23.1 Million USD | -1.89% |
| 2023 Q1 | 23.54 Million USD | -0.46% |
| 2023 FY | 20.23 Million USD | -14.48% |
| 2022 Q2 | 20.1 Million USD | -1.82% |
| 2022 Q4 | 23.65 Million USD | 9.46% |
| 2022 FY | 23.65 Million USD | 16.91% |
| 2022 Q1 | 20.48 Million USD | 1.22% |
| 2022 Q3 | 21.61 Million USD | 7.48% |
| 2021 Q2 | 16.53 Million USD | 53.85% |
| 2021 Q1 | 10.74 Million USD | -10.93% |
| 2021 FY | 20.23 Million USD | 67.74% |
| 2021 Q4 | 20.23 Million USD | -7.63% |
| 2021 Q3 | 21.9 Million USD | 32.5% |
| 2020 Q1 | 10.52 Million USD | 23.67% |
| 2020 Q2 | 10.85 Million USD | 3.11% |
| 2020 Q3 | 11.06 Million USD | 1.98% |
| 2020 Q4 | 12.06 Million USD | 8.99% |
| 2020 FY | 12.06 Million USD | 41.73% |
| 2019 Q3 | 7.97 Million USD | 13.25% |
| 2019 FY | 8.51 Million USD | 222.3% |
| 2019 Q4 | 8.51 Million USD | 6.71% |
| 2019 Q2 | 7.04 Million USD | -5.66% |
| 2019 Q1 | 7.46 Million USD | 182.73% |
| 2018 Q3 | 2.05 Million USD | -0.73% |
| 2018 Q1 | 1.89 Million USD | -28.36% |
| 2018 FY | 2.64 Million USD | 0.0% |
| 2018 Q4 | 2.64 Million USD | 28.64% |
| 2018 Q2 | 2.06 Million USD | 9.3% |
| 2017 Q4 | 2.64 Million USD | 8.77% |
| 2017 FY | 2.64 Million USD | 16.34% |
| 2017 Q1 | 2.8 Million USD | 23.48% |
| 2017 Q2 | 2.83 Million USD | 1.07% |
| 2017 Q3 | 2.42 Million USD | -14.3% |
| 2016 FY | 2.27 Million USD | -43.78% |
| 2016 Q3 | 2.37 Million USD | -30.11% |
| 2016 Q2 | 3.4 Million USD | -13.02% |
| 2016 Q4 | 2.27 Million USD | -4.5% |
| 2016 Q1 | 3.91 Million USD | -3.17% |
| 2015 Q4 | 4.03 Million USD | -4.15% |
| 2015 FY | 4.03 Million USD | 62.04% |
| 2015 Q1 | 2.48 Million USD | -0.36% |
| 2015 Q3 | 4.21 Million USD | 37.59% |
| 2015 Q2 | 3.06 Million USD | 23.32% |
| 2014 Q3 | 2.51 Million USD | 7.56% |
| 2014 Q2 | 2.34 Million USD | 5.07% |
| 2014 FY | 2.49 Million USD | -6.25% |
| 2014 Q4 | 2.49 Million USD | -1.07% |
| 2014 Q1 | 2.22 Million USD | -16.14% |
| 2013 Q2 | 2.02 Million USD | -32.87% |
| 2013 Q4 | 2.65 Million USD | 0.11% |
| 2013 FY | 2.65 Million USD | -18.77% |
| 2013 Q1 | 3 Million USD | -8.04% |
| 2013 Q3 | 2.65 Million USD | 31.44% |
| 2012 Q2 | 4.79 Million USD | 5.82% |
| 2012 Q3 | 4.33 Million USD | -9.63% |
| 2012 Q4 | 3.27 Million USD | -24.52% |
| 2012 FY | 3.27 Million USD | -37.52% |
| 2012 Q1 | 4.53 Million USD | -13.44% |
| 2011 Q4 | 5.23 Million USD | -1.47% |
| 2011 Q2 | 4.33 Million USD | -22.15% |
| 2011 Q1 | 5.57 Million USD | -16.42% |
| 2011 FY | 5.23 Million USD | -21.41% |
| 2011 Q3 | 5.31 Million USD | 22.58% |
| 2010 Q3 | 6.33 Million USD | 10.67% |
| 2010 Q2 | 5.72 Million USD | -10.91% |
| 2010 Q1 | 6.42 Million USD | 7.37% |
| 2010 FY | 6.66 Million USD | 11.35% |
| 2010 Q4 | 6.66 Million USD | 5.18% |
| 2009 Q3 | 6.28 Million USD | -5.62% |
| 2009 Q2 | 6.65 Million USD | -17.17% |
| 2009 Q1 | 8.03 Million USD | -4.06% |
| 2009 FY | 5.98 Million USD | -28.52% |
| 2009 Q4 | 5.98 Million USD | -4.7% |
| 2008 Q2 | 5.12 Million USD | 1.24% |
| 2008 FY | 8.37 Million USD | 59.3% |
| 2008 Q4 | 8.37 Million USD | 31.44% |
| 2008 Q1 | 5.06 Million USD | -3.71% |
| 2008 Q3 | 6.37 Million USD | 24.32% |
| 2007 Q4 | 5.25 Million USD | -10.61% |
| 2007 FY | 5.25 Million USD | -7.48% |
| 2007 Q3 | 5.88 Million USD | -4.28% |
| 2007 Q2 | 6.14 Million USD | 15.49% |
| 2007 Q1 | 5.31 Million USD | -6.37% |
| 2006 Q1 | 1.32 Million USD | -19.48% |
| 2006 Q2 | 1.7 Million USD | 28.65% |
| 2006 FY | 5.68 Million USD | 245.77% |
| 2006 Q4 | 5.68 Million USD | 3.72% |
| 2006 Q3 | 5.47 Million USD | 221.8% |
| 2005 Q3 | 1.71 Million USD | 15.75% |
| 2005 FY | 1.64 Million USD | -22.9% |
| 2005 Q2 | 1.47 Million USD | -20.48% |
| 2005 Q1 | 1.86 Million USD | -12.72% |
| 2005 Q4 | 1.64 Million USD | -4.03% |
| 2004 Q1 | 2.12 Million USD | 27.62% |
| 2004 Q2 | 1.61 Million USD | -23.81% |
| 2004 Q3 | 1.42 Million USD | -11.63% |
| 2004 Q4 | 2.13 Million USD | 49.23% |
| 2004 FY | 2.13 Million USD | 28.22% |
| 2003 FY | 1.66 Million USD | -37.28% |
| 2003 Q4 | 1.66 Million USD | -32.98% |
| 2003 Q3 | 2.48 Million USD | 70.33% |
| 2003 Q2 | 1.45 Million USD | -11.38% |
| 2003 Q1 | 1.64 Million USD | -38.0% |
| 2002 Q1 | 2.85 Million USD | -1.66% |
| 2002 Q2 | 2.73 Million USD | -4.0% |
| 2002 Q3 | 2.56 Million USD | -6.4% |
| 2002 Q4 | 2.65 Million USD | 3.48% |
| 2002 FY | 2.65 Million USD | -8.56% |
| 2001 Q2 | 9.28 Million USD | -6.89% |
| 2001 FY | 2.89 Million USD | -72.38% |
| 2001 Q3 | 8.48 Million USD | -8.53% |
| 2001 Q4 | 2.89 Million USD | -65.86% |
| 2001 Q1 | 9.96 Million USD | -5.0% |
| 2000 Q2 | 12.4 Million USD | -3.88% |
| 2000 Q3 | 11.64 Million USD | -6.12% |
| 2000 Q1 | 12.9 Million USD | -4.25% |
| 2000 FY | 10.49 Million USD | -22.11% |
| 2000 Q4 | 10.49 Million USD | -9.86% |
| 1999 Q4 | 13.47 Million USD | -3.08% |
| 1999 FY | 13.47 Million USD | 39.19% |
| 1999 Q1 | 10.4 Million USD | 7.45% |
| 1999 Q2 | 11 Million USD | 5.77% |
| 1999 Q3 | 13.9 Million USD | 26.36% |
| 1998 Q3 | 9.8 Million USD | -1.01% |
| 1998 Q4 | 9.67 Million USD | -1.24% |
| 1998 Q2 | 9.9 Million USD | -8.33% |
| 1998 Q1 | 10.8 Million USD | -5.26% |
| 1998 FY | 9.67 Million USD | -15.1% |
| 1997 Q2 | 12.2 Million USD | 7.02% |
| 1997 Q4 | 11.4 Million USD | -7.32% |
| 1997 Q3 | 12.3 Million USD | 0.82% |
| 1997 FY | 11.4 Million USD | 4.59% |
| 1997 Q1 | 11.4 Million USD | 4.59% |
| 1996 FY | 10.9 Million USD | 505.56% |
| 1996 Q3 | 11.1 Million USD | 4.72% |
| 1996 Q1 | 11 Million USD | 511.11% |
| 1996 Q2 | 10.6 Million USD | -3.64% |
| 1996 Q4 | 10.9 Million USD | -1.8% |
| 1995 Q2 | 1.6 Million USD | 0.0% |
| 1995 Q3 | 1.3 Million USD | -18.75% |
| 1995 Q4 | 1.8 Million USD | 38.46% |
| 1995 FY | 1.8 Million USD | 12.5% |
| 1995 Q1 | 1.6 Million USD | 0.0% |
| 1994 Q3 | 1.5 Million USD | 36.36% |
| 1994 Q4 | 1.6 Million USD | 6.67% |
| 1994 Q2 | 1.1 Million USD | -21.43% |
| 1994 FY | 1.6 Million USD | -5.88% |
| 1994 Q1 | 1.4 Million USD | -17.65% |
| 1993 FY | 1.7 Million USD | 41.67% |
| 1993 Q4 | 1.7 Million USD | 41.67% |
| 1993 Q3 | 1.2 Million USD | 0.0% |
| 1993 Q2 | 1.2 Million USD | -7.69% |
| 1993 Q1 | 1.3 Million USD | 8.33% |
| 1992 FY | 1.2 Million USD | 50.0% |
| 1992 Q3 | 1.7 Million USD | 0.0% |
| 1992 Q4 | 1.2 Million USD | -29.41% |
| 1991 Q4 | 800 Thousand USD | 0.0% |
| 1991 FY | 800 Thousand USD | -52.94% |
| 1990 Q4 | 1.7 Million USD | 0.0% |
| 1990 FY | 1.7 Million USD | -5.56% |
| 1989 FY | 1.8 Million USD | -5.26% |
| 1989 Q4 | 1.8 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 81.561% |
| AngioDynamics, Inc. | 112.08 Million USD | 79.174% |
| AtriCure, Inc. | 147.76 Million USD | 84.203% |
| Avinger, Inc. | 19.97 Million USD | -16.879% |
| Azenta, Inc. | 351.22 Million USD | 93.354% |
| BioLife Solutions, Inc. | 75.05 Million USD | 68.897% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.432% |
| Daxor Corporation | 858.75 Thousand USD | -2618.228% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -43.103% |
| Femasys Inc. | 9.4 Million USD | -148.244% |
| GlucoTrack, Inc. | 1.7 Million USD | -1266.686% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 63.692% |
| Hologic, Inc. | 4.02 Billion USD | 99.42% |
| ICU Medical, Inc. | 2.25 Billion USD | 98.965% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 98.858% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -187.929% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 52.242% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -3437.161% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -3437.161% |
| Masimo Corporation | 1.67 Billion USD | 98.608% |
| Microbot Medical Inc. | 3.82 Million USD | -510.115% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 6.916% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 97.922% |
| Nephros, Inc. | 3.5 Million USD | -566.372% |
| NovoCure Limited | 783.63 Million USD | 97.021% |
| NEXGEL, Inc. | 4.78 Million USD | -387.43% |
| NEXGEL, Inc. | 4.78 Million USD | -387.43% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 73.002% |
| OraSure Technologies, Inc. | 52.17 Million USD | 55.259% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -41.955% |
| Predictive Oncology Inc. | 6.14 Million USD | -279.841% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -241.033% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.344% |
| Repligen Corporation | 853.2 Million USD | 97.264% |
| Sanara MedTech Inc. | 29.28 Million USD | 20.285% |
| STAAR Surgical Company | 102.73 Million USD | 77.279% |
| Sharps Technology, Inc. | 3.85 Million USD | -505.528% |
| Utah Medical Products, Inc. | 7.14 Million USD | -226.704% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.427% |
| Jin Medical International Ltd. | 8.92 Million USD | -161.565% |